The present invention relates to NMDA antagonists that target the NR2B subunit according to general formula (I) and pharmaceutical compositions comprising compounds according to general formula (I).展开▼
机译：本发明涉及靶向根据通式（I）的NR2B亚基的NMDA拮抗剂，以及包含根据通式（I）的化合物的药物组合物。 <图像文件=“ IMGA0001.GIF” he =“ 40” imgContent =“ chem” imgFormat =“ GIF” wi =“ 65” />
展开▼
